as on September 4, 2025 at 1:29 am IST
Day's Low
Day's High
3.55%
Downside
1.27%
Upside
52 Week's Low
52 Week's High
58.10%
Downside
1.94%
Upside
Check Bridgebio Pharma Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$9.9B
EPS (TTM)
-2.5934
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-10.2
Industry PE ratio
-9.23
P/B Ratio
0PEG Ratio
0EBITDA
-623.7M
Revenue (TTM)
235.8M
Profit Margin
0.00%
Return On Equity TTM
1545100.00%
Track how Bridgebio Pharma Inc P/E has moved over time to understand its valuation trends.
Bridgebio Pharma Inc in the last 5 years
Lowest (0.00x)
September 4, 2025
Today (-10.20x)
September 4, 2025
Industry (-9.23x)
September 4, 2025
Highest (0.00x)
September 4, 2025
Today’s Price to Earnings Ratio: -10.20x
Compare market cap, revenue, PE, and other key metrics of Bridgebio Pharma Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $9.9B | NA | -10.2 | 0.00% | |
BUY | $58.6B | 264.27% | -505.15 | -12.96% | |
NA | $39.4B | NA | NA | -3.89% | |
BUY | $101.7B | NA | 28.25 | 31.86% | |
BUY | $59.8B | -2.85% | 14.21 | 31.37% |
Based on 20 analysts
85.00%
Buy
15.00%
Hold
0.00%
Sell
Based on 20 analysts, 85% of analysts recommend a 'BUY' rating for Bridgebio Pharma Inc. Average target price of $63.81
Get share price movements and forecasts by analysts on Bridgebio Pharma Inc.
What analysts predicted
18.76%UPSIDE
Target Price
$63.81
Current Price
$51.84
Analyzed by
20 Analysts
Target
$63.81
Bridgebio Pharma Inc target price $63.81, a slight upside of 18.76% compared to current price of $51.84. According to 20 analysts rating.
Search interest for Bridgebio Pharma Inc Stock has increased by 48% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:48% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 03 September
Wed, 04:40 PM
-H.C. Wainwright also maintains Buy rating, increasing price target from $56 to $70, with all analysts rating it Buy.
Wed, 05:11 PM
-J.P. Morgan maintains Buy rating on BridgeBio, raising price target to $70, citing strong pipeline and product launch.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 3 years, BBIO stock has moved up by 415.6%
Best in 3 Years
In the last 3 years, BBIO has outperformed top 5 stocks with highest market-cap in its industry
Against Peers
In the last 1 year, Beone Medicines Ltd has given 78.4% return, outperforming this stock by 9.3%
Profit Down
Netprofit is down for the last 2 quarters, -167.42M → -181.90M (in $), with an average decrease of 8.7% per quarter
Revenue Fall
Revenue is down for the last 2 quarters, 116.63M → 110.56M (in $), with an average decrease of 5.2% per quarter
Organisation | Bridgebio Pharma Inc |
Headquarters | 3160 Porter Drive, Palo Alto, CA, United States, 94304 |
Industry | Health Technology |
CEO | Dr. Neil Kumar Ph.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Dr. Thomas Trimarchi Ph.D. | CFO & President |
Dr. Charles J. Homcy M.D. | Co-Founder, Chairman of Pharmaceuticals & Independent Lead Director |
Ms. Maricel M. Apuli | Chief Accounting Officer |
Dr. Uma Sinha Ph.D. | Chief Scientific Officer |
Dr. Richard H. Scheller Ph.D. | Chairman of Research & Development |
Dr. Neil Kumar Ph.D. | Co-Founder, CEO & Director |
Dr. Frank P. McCormick Ph.D. | Co-Founder, Chairman of Oncology & Director |
Mr. Eli M. Wallace Ph.D. | Chief Scientific Officer of Oncology |
Dr. Eric Michael David J.D., M.D., Ph.D. | Chief Executive Officer of Gene Therapy |
Mr. Matthew Outten CPC, MBA | Chief Commercial Officer |
Bridgebio Pharma Inc share price today is $51.84 as on at the close of the market. Bridgebio Pharma Inc share today touched a day high of $52.5 and a low of $50.
Bridgebio Pharma Inc share touched a 52 week high of $52.85 on and a 52 week low of $21.72 on . Bridgebio Pharma Inc stock price today i.e. is closed at $51.84,which is 1.90% down from its 52 week high and 138.67% up from its 52 week low.
Bridgebio Pharma Inc market capitalisation is $0.01T as on .
Indian investors can start investing in Bridgebio Pharma Inc (BBIO) shares with as little as ₹88.035 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.35 in Bridgebio Pharma Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Bridgebio Pharma Inc share’s latest price of $51.84 as on September 4, 2025 at 1:29 am IST, you will get 0.1929 shares of Bridgebio Pharma Inc. Learn more about
fractional shares .